RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 455.93 Million | 356.77 Million | 238.16 Million | 331.5 Million | 320.14 Million | 178.47 Million |
| Net Income | 81.57 Million | 32.37 Million | -58.67 Million | -6.47 Million | 62.6 Million | 90.76 Million |
| Depreciation & Amortization | 286.15 Million | 297 Million | 250 Million | 214 Million | 183 Million | 114 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 61.38 Million | 42.11 Million | 52.55 Million | 131.97 Million | 84.37 Million | 37.15 Million |
| Other non-cash items | 537.74 Million | -14.71 Million | -5.71 Million | -7.98 Million | -9.83 Million | -63.44 Million |
| Investing Cash Flow | -209.33 Million | -231.5 Million | -237.63 Million | -225.59 Million | -212.04 Million | -223.62 Million |
| Investments in PPE | -209.33 Million | -231.5 Million | -255.22 Million | -225.59 Million | -212.04 Million | -223.63 Million |
| Acquisitions | - | - | - | - | - | 9000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -185.03 Million | -187.98 Million | 17.59 Million | -195.88 Million | -164.81 Million | 9000.00 |
| Financing Cash Flow | -56.35 Million | -78.49 Million | -72.23 Million | -44.02 Million | -111.48 Million | 46.95 Million |
| Debt repayment | -56.35 Million | -21.26 Million | -49.65 Million | -44.02 Million | -75 Million | -46.95 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -56.35 Million | -57.22 Million | -22.58 Million | -44.02 Million | -36.48 Million | 46.95 Million |
| Accounts receivables | 31.78 Million | -66.03 Million | 27.05 Million | 52.15 Million | 45.33 Million | -20.3 Million |
| Accounts payables | 29.6 Million | 108.15 Million | 56 Million | 79.82 Million | 39.03 Million | 57.46 Million |
| Inventory | -29.6 Million | -108.15 Million | - | -79.82 Million | -39.03 Million | - |
| Other working capital | 29.6 Million | 108.15 Million | -30.5 Million | 79.82 Million | 39.03 Million | 57.46 Million |
| Cash at beginning of period | 160.26 Million | 102.53 Million | 168.74 Million | 113.85 Million | 112.19 Million | 104.15 Million |
| Cash at end of period | 343.68 Million | 160.26 Million | 102.53 Million | 168.74 Million | 113.85 Million | 112.19 Million |
| Capital Expenditure | -209.33 Million | -231.5 Million | -255.22 Million | -225.59 Million | -212.04 Million | -223.63 Million |
| Effect of forex changes on cash | -6.83 Million | 10.94 Million | 5.49 Million | -7 Million | 5.04 Million | 6.23 Million |
| Net cash flow / Change in cash | 183.41 Million | 57.73 Million | -66.21 Million | 54.88 Million | 1.66 Million | 8.04 Million |
| Free Cash Flow | 246.6 Million | 125.27 Million | -17.06 Million | 105.91 Million | 108.09 Million | -45.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 61.43 Million | 36.69 Million | 31.54 Million | 81.57 Million | 27.85 Million | 16.77 Million |
| Depreciation & Amortization | 46.4 Million | 73.1 Million | 75.31 Million | 286.15 Million | 28.21 Million | 68.3 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 7.33 Million | 73.87 Million | -9.32 Million | 61.38 Million | 17.79 Million | -4.1 Million |
| Other non-cash items | 78.45 Million | 55.96 Million | 178.18 Million | 537.74 Million | 50.51 Million | -13.75 Million |
| Investing Cash Flow | -57.93 Million | -60.8 Million | -64.58 Million | -209.33 Million | -43.67 Million | -56.45 Million |
| Investments in PPE | -57.93 Million | -60.8 Million | -64.58 Million | -209.33 Million | -43.67 Million | -56.45 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -54.63 Million | -50.03 Million | -57.16 Million | -185.03 Million | -34.79 Million | -45.91 Million |
| Financing Cash Flow | -100.85 Million | -18.64 Million | -5.66 Million | -56.35 Million | -17.16 Million | -14.04 Million |
| Debt repayment | -32.29 Million | -18.64 Million | -5.66 Million | -56.35 Million | -17.16 Million | -14.04 Million |
| Dividends payments | -68.56 Million | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -32.29 Million | - | -5.66 Million | - | - | -14.04 Million |
| Accounts receivables | -17.33 Million | 11.58 Million | -20.53 Million | 31.78 Million | 20.23 Million | -18 Million |
| Accounts payables | 24.66 Million | 62.28 Million | 11.21 Million | 29.6 Million | -7.56 Million | 16.4 Million |
| Inventory | - | - | -11.21 Million | -29.6 Million | - | - |
| Other working capital | 24.66 Million | 62.28 Million | 11.21 Million | 29.6 Million | 5.11 Million | -2.5 Million |
| Cash at beginning of period | 440.13 Million | 343.68 Million | 306.63 Million | 160.26 Million | 246.22 Million | 243.71 Million |
| Cash at end of period | 435.19 Million | 440.13 Million | 343.68 Million | 343.68 Million | 306.63 Million | 246.22 Million |
| Capital Expenditure | -57.93 Million | -60.8 Million | -64.58 Million | -209.33 Million | -43.67 Million | -56.45 Million |
| Effect of forex changes on cash | -686 Thousand | 8.59 Million | -8.47 Million | -6.83 Million | -3.13 Million | 5.79 Million |
| Net cash flow / Change in cash | -4.93 Million | 96.45 Million | 37.04 Million | 183.41 Million | 60.4 Million | 2.5 Million |
| Free Cash Flow | 96.61 Million | 106.49 Million | 51.19 Million | 246.6 Million | 80.7 Million | 10.75 Million |
ANANTRAJ
3961
MODULEX
001259
DTNOY
3625